Los puntos clave no están disponibles para este artículo en este momento.
This systematic review found that platform trials were initiated most frequently during the COVID-19 pandemic and declined thereafter. The reporting of platform features and the availability of results were insufficient. Premature arm closure for poor recruitment was rare.
Griessbach et al. (Wed,) studied this question.